NASDAQ:CHRN ChronoScale Corporation Common Stock (CHRN) Stock Price, News & Analysis $15.48 -0.01 (-0.06%) As of 05/22/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About ChronoScale Corporation Common Stock Stock (NASDAQ:CHRN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CHRN alerts:Sign Up Key Stats Today's Range$15.35▼$16.6350-Day Range$8.02▼$17.9252-Week Range$2.73▼$20.34Volume180,664 shsAverage Volume293,139 shsMarket Capitalization$55.11 millionP/E RatioN/ADividend YieldN/APrice Target$6.00Consensus RatingReduce Company Overview Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks. In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions. These devices are utilized in hospitals and rehabilitation centers across North America and Europe, enabling physical therapists to deliver overground gait training with customizable robotic support and integrated performance tracking. On the industrial side, EksoWorks exoskeletons—including the EksoVest and EksoZeroG—help reduce workplace fatigue and lower the risk of musculoskeletal injuries in manufacturing, warehousing and automotive assembly. By offloading weight and supporting the arms or torso, these wearable solutions improve ergonomics, enhance worker safety and boost productivity in environments that involve repetitive overhead or lifting tasks. Ekso Bionics serves a global customer base spanning the United States, Europe and Asia. The company’s leadership team, led by Chief Executive Officer Paul R. Sandner, brings together expertise in robotics, biomechanics and healthcare to drive ongoing innovation and expand market adoption of wearable robotics technologies.AI Generated. May Contain Errors. Read More ChronoScale Corporation Common Stock Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks20th Percentile Overall ScoreCHRN MarketRank™: ChronoScale Corporation Common Stock scored higher than 20% of companies evaluated by MarketBeat, and ranked 792nd out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingChronoScale Corporation Common Stock has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Downside RiskChronoScale Corporation Common Stock has a consensus price target of $6.00, representing about 61.2% downside from its current price of $15.48.Amount of Analyst CoverageChronoScale Corporation Common Stock has only been the subject of 1 research reports in the past 90 days.Read more about ChronoScale Corporation Common Stock's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for ChronoScale Corporation Common Stock are expected to grow in the coming year, from ($0.10) to ($0.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ChronoScale Corporation Common Stock is -2.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ChronoScale Corporation Common Stock is -2.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioChronoScale Corporation Common Stock has a P/B Ratio of 26.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about ChronoScale Corporation Common Stock's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.48% of the float of ChronoScale Corporation Common Stock has been sold short.Short Interest Ratio / Days to CoverChronoScale Corporation Common Stock has a short interest ratio ("days to cover") of 2.32, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in ChronoScale Corporation Common Stock has recently increased by 9.24%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldChronoScale Corporation Common Stock does not currently pay a dividend.Dividend GrowthChronoScale Corporation Common Stock does not have a long track record of dividend growth. News and Social Media1.3 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for ChronoScale Corporation Common Stock this week, compared to 2 articles on an average week.Search Interest20 people have searched for CHRN on MarketBeat in the last 30 days. MarketBeat Follows4 people have added ChronoScale Corporation Common Stock to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership3.2 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $15,500.00 in company stock, which represents 0.0281% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, ChronoScale Corporation Common Stock insiders have bought more of their company's stock than they have sold. Specifically, they have bought $15,500.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders6.90% of the stock of ChronoScale Corporation Common Stock is held by insiders.Percentage Held by Institutions6.42% of the stock of ChronoScale Corporation Common Stock is held by institutions.Read more about ChronoScale Corporation Common Stock's insider trading history. Receive CHRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ChronoScale Corporation Common Stock and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CHRN Stock News HeadlinesChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Crosses Above 50-Day Moving Average - Here's What HappenedMay 22 at 4:56 AM | americanbankingnews.comChronoScale Corp.May 21, 2026 | barrons.comNobody Understands Why Trump Is Invading Iran (here’s the answer)Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now. | Banyan Hill Publishing (Ad)CHRN stock just started trading as Applied Digital spins off ChronoScale. How to play shares here.May 7, 2026 | msn.comChronoScale CorporationMay 7, 2026 | cnn.comChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute GrowthMay 6, 2026 | globenewswire.comApplied Digital's quarterly net loss widens on rising costs, one-time chargeApril 8, 2026 | msn.comEkso Bionics Holdings, Inc.April 3, 2026 | edition.cnn.comSee More Headlines CHRN Stock Analysis - Frequently Asked Questions How have CHRN shares performed this year? ChronoScale Corporation Common Stock's stock was trading at $8.64 on January 1st, 2026. Since then, CHRN shares have increased by 79.2% and is now trading at $15.48. How were ChronoScale Corporation Common Stock's earnings last quarter? ChronoScale Corporation Common Stock (NASDAQ:CHRN) announced its quarterly earnings results on Tuesday, April, 28th. The company reported ($2.04) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by $2.01. The company had revenue of $2.14 million for the quarter, compared to analyst estimates of $4.29 million. ChronoScale Corporation Common Stock had a negative trailing twelve-month return on equity of 197.81% and a negative net margin of 135.66%. When did ChronoScale Corporation Common Stock's stock split? ChronoScale Corporation Common Stock shares reverse split before market open on Monday, June 2nd 2025.The 1-15 reverse split was announced on Monday, May 19th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. Who are ChronoScale Corporation Common Stock's major shareholders? Top institutional investors of ChronoScale Corporation Common Stock include Roble Belko & Company Inc (0.07%). Insiders that own company stock include Daniel Asher, Scott G Davis and Jerome Wong. View institutional ownership trends. How do I buy shares of ChronoScale Corporation Common Stock? Shares of CHRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of ChronoScale Corporation Common Stock own? Based on aggregate information from My MarketBeat watchlists, some other companies that ChronoScale Corporation Common Stock investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), TransEnterix (TRXDW), Meta Platforms (META), Tesla (TSLA), Editas Medicine (EDIT) and Micron Technology (MU). Company Calendar Last Earnings4/28/2026Today5/24/2026Next Earnings (Estimated)7/27/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (8m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 CHRN's financial health is in the Green zone, according to TradeSmith. CHRN has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMachinery Current SymbolNASDAQ:CHRN Previous SymbolNASDAQ:EKSO CIK1549084 Webwww.eksobionics.com Phone510-984-1761Fax510-927-2647Employees60Year Founded2005Price Target and Rating Average Price Target for ChronoScale Corporation Common Stock$6.00 High Price Target$6.00 Low Price Target$6.00 Potential Upside/Downside-61.2%Consensus RatingReduce Rating Score (0-4)1.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($5.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.69 million Net Margins-135.66% Pretax Margin-135.66% Return on Equity-197.81% Return on Assets-74.17% Debt Debt-to-Equity Ratio0.25 Current Ratio1.55 Quick Ratio1.03 Sales & Book Value Annual Sales$12.80 million Price / Sales4.31 Cash FlowN/A Price / Cash FlowN/A Book Value$0.59 per share Price / Book26.24Miscellaneous Outstanding Shares3,560,000Free Float3,317,000Market Cap$55.11 million OptionableNo Data Beta0.86 Social Links Beginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:CHRN) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ChronoScale Corporation Common Stock Please log in to your account or sign up in order to add this asset to your watchlist. Share ChronoScale Corporation Common Stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
